Tech Company Financing Transactions
Orum Therapeutics Funding Round
Orum Therapeutics, based in Cambridge, secured $30 million from IMM Investment, InterVest and KB Partners.
Transaction Overview
Company Name
Announced On
7/18/2019
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Investors
Proceeds Purpose
The proceeds of the financing will be used to expand Oromab, Orum's proprietary cell-specific, cell-penetrating antibody platform technology that targets undruggable proteins and delivers a variety of therapeutic payloads.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20 Acorn Park Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies to bring new medicines to patients with unmet medical needs. Orum leverages its unique cell penetrating antibody platform to inhibit drug targets undruggable by small molecule or current antibody therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
SJ Lee
Chief Scientific Officer
Peter Park
Browse more venture capital transactions:
Prev: 7/18/2019: VendAsta venture capital transaction
Next: 7/18/2019: Ascend venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs